Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus
暂无分享,去创建一个
S. Cross | M. Beckmann | P. Fasching | A. Børresen-Dale | C. Vachon | Jingmei Li | K. Czene | P. Hall | F. Couch | H. Brenner | J. Chang-Claude | S. Chanock | M. García-Closas | J. Benítez | Sofia Khan | G. Giles | J. Hopper | C. Haiman | T. Dörk | M. Southey | A. Lophatananon | L. Marchand | A. Cox | D. Easton | A. Hollestelle | J. Martens | Chen-Yang Shen | A. Broeks | P. Pharoah | Kai Yu | N. Orr | L. Prokunina-Olsson | H. Brauch | V. Kristensen | X. Shu | Charles C. Chung | W. Zheng | H. Anton-Culver | P. Guénel | W. Blot | A. Dunning | P. Brennan | S. Sangrajrang | O. Fletcher | N. Johnson | G. Chenevix-Trench | S. Bojesen | H. Nevanlinna | D. Kang | N. Bogdanova | P. Devilee | R. Milne | A. González-Neira | U. Hamann | A. Mannermaa | V. Kosma | M. Shah | K. Muir | A. Lindblom | K. Michailidou | J. Dennis | M. Schmidt | M. Bolla | Qin Wang | A. Meindl | R. Schmutzler | C. Luccarini | H. Flyger | A. Rudolph | T. Truong | F. Marmé | B. Burwinkel | E. Sawyer | I. Tomlinson | I. Andrulis | J. Knight | S. Margolin | V. Arndt | A. Swerdlow | J. Figueroa | M. Goldberg | R. Winqvist | A. Jukkola-Vuorinen | P. Radice | C. Seynaeve | A. Jakubowska | J. Lubiński | S. Slager | K. Matsuo | H. Iwata | A. Wu | S. Teo | M. Hartman | Q. Cai | M. Shrubsole | J. Simard | H. Darabi | S. Neuhausen | D. Torres | D. Yannoukakos | C. Baynes | K. Chia | M. Hou | N. Taib | A. Smeets | M. Kabisch | W. Lu | Ji-Yeob Choi | M. Barile | Han Zhang | Hui Zhao | P. Harrington | Hisani N. Horne | David ven den Berg
[1] Gabor T. Marth,et al. A global reference for human genetic variation , 2015, Nature.
[2] Peter C Scacheri,et al. Enhancer variants: evaluating functions in common disease , 2014, Genome Medicine.
[3] D. Noh,et al. Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1 , 2014, Nature Genetics.
[4] Jane E. Carpenter,et al. Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer. , 2014, Carcinogenesis.
[5] Hong Yang,et al. Notch-1 Signaling Promotes the Malignant Features of Human Breast Cancer through NF-κB Activation , 2014, PloS one.
[6] Julian Peto,et al. Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast , 2014, PLoS genetics.
[7] R. Young,et al. Super-Enhancers in the Control of Cell Identity and Disease , 2013, Cell.
[8] T. Das,et al. Silencing NOTCH signaling causes growth arrest in both breast cancer stem cells and breast cancer cells , 2013, British Journal of Cancer.
[9] Qian Chen,et al. Assessing Interactions between the Association of Common Genetic Variant at 1p11 (rs11249433) and Hormone Receptor Status with Breast Cancer Risk , 2013, PloS one.
[10] Hongwei Zhang,et al. Association between 1p11-rs11249433 Polymorphism and Breast Cancer Susceptibility: Evidence from 15 Case-Control Studies , 2013, PloS one.
[11] Wei Zheng,et al. Evaluating Genome-Wide Association Study-Identified Breast Cancer Risk Variants in African-American Women , 2013, PloS one.
[12] Jaana M. Hartikainen,et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk , 2013, Nature Genetics.
[13] Wei Lu,et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer , 2013, Nature Genetics.
[14] Patrick Neven,et al. Genome-wide association studies identify four ER negative–specific breast cancer risk loci , 2013, Nature Genetics.
[15] Stephen M. Hewitt,et al. Breast cancer susceptibility risk associations and heterogeneity by E-cadherin tumor tissue expression , 2013, Breast Cancer Research and Treatment.
[16] Jane E. Carpenter,et al. A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. , 2012, Human molecular genetics.
[17] D. Noh,et al. Genome-Wide Association Study in East Asians Identifies Novel Susceptibility Loci for Breast Cancer , 2012, PLoS genetics.
[18] Michael Jones,et al. Genome-wide association analysis identifies three new breast cancer susceptibility loci , 2012, Nature Genetics.
[19] Jane E. Carpenter,et al. A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer , 2011, Nature Genetics.
[20] Hongbing Shen,et al. Genetic Variants at 1p11.2 and Breast Cancer Risk: A Two-Stage Study in Chinese Women , 2011, PloS one.
[21] Michael Jones,et al. Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. , 2011, Human molecular genetics.
[22] Michael Jones,et al. Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study. , 2011, Journal of the National Cancer Institute.
[23] Peter H. Sudmant,et al. Diversity of Human Copy Number Variation and Multicopy Genes , 2010, Science.
[24] Christiana Kartsonaki,et al. A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population , 2010, Nature Genetics.
[25] D. Altshuler,et al. A map of human genome variation from population-scale sequencing , 2010, Nature.
[26] Sharon R Grossman,et al. Integrating common and rare genetic variation in diverse human populations , 2010, Nature.
[27] Deborah Hughes,et al. Genome-wide association study identifies five new breast cancer susceptibility loci , 2010, Nature Genetics.
[28] Ashraful Hoque,et al. Single nucleotide differences (SNDs) in the dbSNP database may lead to errors in genotyping and haplotyping studies , 2010, Human mutation.
[29] K. Mimori,et al. Notch pathway as candidate therapeutic target in Her2/Neu/ErbB2 receptor-negative breast tumors. , 2009, Oncology reports.
[30] C. E. Pearson,et al. Table S2: Trans-factors and trinucleotide repeat instability Trans-factor , 2010 .
[31] A. Børresen-Dale,et al. NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations , 2010, Molecular Cancer.
[32] P. Donnelly,et al. A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.
[33] M. Thun,et al. Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2 , 2009, Nature Genetics.
[34] W. Willett,et al. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1) , 2009, Nature Genetics.
[35] J. Haines,et al. Genome-wide association study identifies a novel breast cancer susceptibility locus at 6q25.1 , 2009, Nature Genetics.
[36] J. Visvader,et al. Notch signaling regulates mammary stem cell function and luminal cell-fate commitment. , 2008, Cell stem cell.
[37] A. Sigurdsson,et al. Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer , 2008, Nature Genetics.
[38] D. Gudbjartsson,et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer , 2007, Nature Genetics.
[39] Lester L. Peters,et al. Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.
[40] W. Willett,et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer , 2007, Nature Genetics.
[41] Fangting Wu,et al. Notch signaling and its role in breast cancer. , 2007, Frontiers in bioscience : a journal and virtual library.
[42] Augustin Luna,et al. snp.plotter: an R-based SNP/haplotype association and linkage disequilibrium plotting package , 2007, Bioinform..
[43] G. Watkins,et al. The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumour clinicopathological parameters in human breast cancer. , 2004, International journal of molecular medicine.
[44] Tom H. Pringle,et al. The human genome browser at UCSC. , 2002, Genome research.